Selexis CHO Cells in Suspension-1

Archives 2013

Selexis has been setting the pace of innovation in protein expression and establishing new benchmarks in bioproduction for  two decades.

DECEMBER 17, 2013
1 min read

Selexis SA to Address Recombinant Protein Expression Bottlenecks at PEPTALK 2014

Selexis CSO to Present Data on the Recently Launched SURE CHO-Mplus™ Libraries

Geneva, Switzerland December 17, 2013 –...

Read More
DECEMBER 3, 2013
2 min read

JHL Biotech, Inc. and Selexis SA Form Biologic Drug Development Alliance to Serve the Biopharmaceutical Industry

Strategic Alliance to Provide Seamless Services from Cell Line Development to cGMP Manufacturing of Biologic Drugs

...

Read More
NOVEMBER 19, 2013
1 min read

Selexis Names Dr. Marco Bocci Director of European Sales and Business Develpment

Former Quintile executive brings more than 15 years of life science and regulatory knowledge to Selexis

Geneva,...

Read More
OCTOBER 24, 2013
1 min read

Selexis SA to Present and Partner at the BIO-Europe 2013 Partnering Conference

Dr. Igor Fisch to Present Data on Using the SURE CHO-Mplus Combinatorial Library to Address a Broad Range of Protein...

Read More
JULY 31, 2013
1 min read

Selexis SA to Present Data on Improved Selection of Recombinant Protein Production Clones at the Bioprocessing Summit 2013

CSO to Present Data on Using the SURE CHO-Mplus Combinatorial Library to Address a Broad Range of Protein Production...

Read More
JULY 16, 2013
1 min read

Selexis to Exhibit at BIO Taiwan 2013

Selexis to Meet with Companies Interested in Protein Drug Discovery, Cell Line Development and Lead Identification for...

Read More
MAY 20, 2013
2 min read

Selexis SA to Present Technology Platform Data at Cell Line Development & Engineering

Geneva, Switzerland (PRWEB) May 20, 2013 – Selexis SA, a serial innovation company focused on drug discovery for lead...

Read More
APRIL 30, 2013
1 min read

Selexis SA Sells Rights to Royalty Payments for More Than 15 Biologic Development Programs to Ligand Pharmaceuticals

Funding to Expand the SUREtechnology Platform™

Geneva, Switzerland (PRNEWSWIRE) April 30, 2013 – Selexis SA, a serial...

Read More
APRIL 23, 2013
1 min read

Selexis SA to Speak on Next Generation Innovations for Secretion Bottlenecks at the 2013 Protein Engineering Summit (PEGS)

Company to Present Data on recently launched Selexis SURE CHO-Mplus™ Libraries

Geneva, Switzerland (PRWEB) April 23,...

Read More
APRIL 10, 2013
1 min read

Selexis to Partner and Exhibit at BIO 2013

Selexis to Meet with Companies Interested in Cell Line Development and Lead Identification for Therapeutic Drug...

Read More
MARCH 8, 2013
1 min read

Selexis SA to Present and Partner at the BIO-Europe Spring

Dr. Armelle Gaussin to Present in the Cell Therapy/Regenerative Medicine Track

Geneva, Switzerland (PRWEB) March 8,...

Read More
MARCH 5, 2013
1 min read

Selexis Announces Publication in Metabolic Engineering of Data Demonstrating Improvement of Therapeutic Protein Secretion with Engineered CHO Cells

New Paper Highlights Innovations in the SUREtechnology Platform™ for the Improvement of Protein Secretion of...

Read More